Home
Storia in 2 fonti
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
Hengrui Pharma has lined up Bristol Myers Squibb as its latest partner in a deal worth up to $15.2 billion. The total value of the pact marks one of the largest East-to-West cross-border deals in industry history.
- ·
biopharmadive.com
Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
The wide-ranging pact involves as many as 13 drugs and marks the latest example of the growing relationship between Chinese pharmaceutical firms and their U.S. and Europe-based…
- ·
endpoints.news
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B
Hengrui Pharma has lined up Bristol Myers Squibb as its latest partner in a deal worth up to $15.2 billion. The total value of the pact marks one of the largest East-to-West…